Posts

G6PD Deficiency and Oxidative Stress: Gene Function, Disease Mechanisms, and Clinically Relevant Variants

Image
What is G6PD? An Overview of the Gene, Enzyme, and Oxidative Stress Pathway Glucose-6-phosphate dehydrogenase (G6PD) is a critical metabolic enzyme encoded by the G6PD gene. It functions as the first and rate-limiting enzyme in the pentose phosphate pathway (PPP), a metabolic route that serves as a central hub for cellular antioxidant defense and nucleotide synthesis. G6PD catalyzes the oxidation of glucose-6-phosphate, generating two essential products: NADPH, the primary source of reducing power for cellular redox balance, and ribose-5-phosphate, a key precursor for nucleotide biosynthesis. NADPH is indispensable for regenerating reduced glutathione (GSH), which directly determines a cell’s ability to neutralize oxidative stress. Consequently, proper G6PD activity is essential for maintaining erythrocyte integrity and supports the unique metabolic demands of tumor cells. The G6PD gene is located on the X chromosome (Xq28). More than 230 point mutations have been identified, and appro...
Post a Comment
Read more

How Lipoprotein Particles Shape Lipid Metabolism and Disease: From Cellular Response Mechanisms to CRISPR KO Models

Image
  When the metabolic balance of lipoprotein particles in the blood is disrupted, it triggers chronic inflammation—the common root of atherosclerosis, metabolic syndrome, and even neurodegenerative diseases. Circulating lipoprotein particles are the primary carriers of cholesterol and triglycerides: low-density lipoprotein (LDL) delivers cholesterol to tissues, while high-density lipoprotein (HDL) recycles it via reverse transport. Together, they maintain the delicate balance of lipid metabolism. When this balance is broken—such as through oxidative deposition of LDL or dysfunction of HDL—damage-associated molecular patterns (DAMPs) like oxidized phospholipids (OxPLs) activate innate immune signaling, driving foam cell formation and metabolic inflammation. Pathway enrichment analysis shows that lipoprotein response pathways are significantly enriched in functional genomics (FDR = 1.11×10⁻⁵), further confirming their role as key regulatory hubs. With CRISPR gene editing technology, i...
Post a Comment
Read more

Response to Lipoprotein Particle Pathway KO Cell Lines

Image
Overview of the Lipoprotein Response Pathway What is the Lipoprotein Response? The Response to Lipoprotein Particle Pathway refers to the key biological processes by which cells or organisms react to stimulation by lipoprotein particles such as LDL, HDL, and VLDL (Gene Ontology term: GO:0055094). Lipoproteins are responsible for transporting lipids, including cholesterol, triglycerides, and phospholipids, through the bloodstream. Maintaining their metabolic homeostasis is essential for cellular function, energy balance, and endocrine regulation. Disruption of lipoprotein metabolism can directly lead to major metabolic diseases, including atherosclerosis, hyperlipidemia, non-alcoholic fatty liver disease (NAFLD), obesity, and type 2 diabetes. Regulatory Network of the Lipoprotein Response The Response to Lipoprotein Particle Pathway regulates multiple biological processes, including lipid uptake, inflammatory responses, cholesterol homeostasis, and innate immune signaling. When lipoprot...
Post a Comment
Read more

KRAS Mutant Cell Lines for Precision Oncology: From Allele-Specific Signaling to Targeted Therapy Resistance

Image
KRAS is one of the most frequently mutated oncogenes in human cancers, yet different mutation subtypes (G12C, G12D, G12V, G13D, etc.) exhibit significant differences in oncogenic potential, signaling pathway preferences, and drug sensitivity. The approval of the first G12C inhibitor in 2021 ushered in a new era of precision targeting of KRAS. Understanding allele-specific functions, screening sensitive drugs, and dissecting resistance mechanisms all rely on isogenic cell models with consistent genetic backgrounds. This article systematically reviews the clinical significance and therapeutic breakthroughs of major KRAS mutation subtypes, and introduces EDITGENE’s off-the-shelf cell lines with KRAS point mutation in HCT116 and LLC, built on the Bingo™ PE7 platform .  These ready-to-ship cell lines provide academic institutes and pharmaceutical companies with ideal tools ranging from in vitro screening to in vivo efficacy evaluation. KRAS mutation spectrum: heterogeneous distribution...
Post a Comment
Read more

Mitophagy Mechanisms in Disease: PINK1/Parkin and BNIP3/NIX Pathways

Image
  Mitochondrial autophagy, also known as mitophagy, is a selective form of autophagy that specifically removes damaged or superfluous mitochondria from cells. It plays a central role in maintaining mitochondrial quality control, reducing the accumulation of reactive oxygen species (ROS), and regulating cellular energy metabolism and homeostasis. In recent years, a growing body of research has demonstrated that dysregulation of mitophagy is closely associated with a wide range of diseases, including neurodegenerative disorders, cancer, cardiovascular diseases, and metabolic dysfunction. Therefore, systematically elucidating its molecular mechanisms and validating its functions using precise models has become a major focus of current research. Mechanisms of Mitophagy At its core, mitophagy involves the sequestration of specific mitochondria by autophagosomes, followed by their delivery to lysosomes for degradation. This process typically includes several key steps: ● Damage recogniti...
Post a Comment
Read more

VEGF Signaling Pathway Knockout Cell Lines for Angiogenesis & Disease Research

Image
Overview of the VEGF Signaling Pathway The VEGF (Vascular Endothelial Growth Factor) signaling pathway is a key regulator of angiogenesis, playing a critical role in both physiological and pathological conditions. It promotes the orderly formation of new blood vessels by regulating endothelial cell (EC) proliferation, migration, and survival. The VEGF family consists of multiple ligands, among which VEGF-A is the most potent driver of angiogenesis. VEGF-A isoforms, generated through alternative splicing, exhibit distinct biological properties: VEGF-A165: the most abundant isoform with strong pro-angiogenic activity and heparin-binding capability VEGF-A121: highly diffusible but with relatively lower activity VEGF-A189: tightly binds to the extracellular matrix, forming localized concentration gradients VEGF-B and PlGF (Placental Growth Factor) primarily bind to VEGFR-1, contributing to metabolic regulation and pathological angiogenesis VEGF-C and VEGF-D are synthesized as precursors an...
Post a Comment
Read more

TP53 Point Mutation, from molecular mechanisms to therapeutic strategies

Image
The TP53 gene , also known as the p53 gene, is one of the most critical tumor suppressor genes in the human genome. Discovered in 1979 and recognized for its tumor-suppressive function in 1989, TP53 has since been regarded as the “guardian of the genome” and remains a central focus of cancer research. Under normal physiological conditions, the TP53 gene functions as a tightly regulated stress-response hub . The p53 protein encoded by the TP53 gene is constantly produced but also rapidly degraded. Upon DNA damage, replication stress, or metabolic imbalance, p53 becomes stabilized and activated, allowing it to orchestrate cell fate decisions. Rather than simply inducing apoptosis, p53 exerts a context-dependent regulatory role: In response to mild damage, p53 induces cell cycle arrest through transcriptional activation of targets such as p21, allowing time for DNA repair. Under moderate stress, p53 promotes DNA repair pathways and antioxidant responses. When damage is irreversible, ...
Post a Comment
Read more